Hamza Asumah MD, MBA, MPH
For about a decade, dental group value was largely a function of how fast you could add locations. Capital was cheap, multiples were high, and acquisition was the strategy.
That era has closed, and the numbers are unambiguous about it.
Large DSO valuation multiples have compressed to 9–10x EBITDA, down from historical peaks of 13–16x in 2019–2021. Smaller practices have adjusted back toward traditional 5–6x ranges. In response, the industry is shifting away from rapid expansion models toward operational excellence, margin improvement, and same-store growth.
Meanwhile EBITDA itself has declined roughly 5% since 2022 across the sector, driven by rising costs against stagnant reimbursement.
Put those together and you get a straightforward strategic reality: you cannot buy your way to value in this market, and the margin you have is eroding underneath you. Which means margin has to be built deliberately. As one industry executive put it, EBITDA can no longer be treated as an outcome — it has to be engineered.
What “engineered” actually means
Not cost-cutting. The levers being named across the 2026 outlook work are structural: technology standardization, revenue cycle optimization, workflow automation, API-driven integration, and AI modernization. Each is worth translating into what it means on a Tuesday.
Technology standardization. A group running four practice management systems, three imaging platforms, and a different phone system at every location cannot centralize anything — not reporting, not scheduling, not billing, not training. Every process has to be rebuilt per site. Standardization is not an IT preference; it is the precondition for every other operational lever.
It also matters at exit. A buyer reads your technology stack as a proxy for the post-close integration work they are inheriting. Multi-server, multi-platform, non-standardized groups get discounted for exactly that. Standardization has quietly become an exit-readiness item.
Revenue cycle optimization. The single largest and most reliable EBITDA lever available. For a group at $10M in gross production, closing the average operational gap between production and cash adds roughly $890,000 in annual EBITDA without touching the top line. Median net collection rate sits at 88.9%. AR over 90 days runs around 55% of total AR. This is margin that already exists.
Workflow automation. The specific target is administrative labor in a market where labor is the constraint. Insurance verification, claims follow-up, appointment confirmation, waitlist filling, recall outreach. Not because software is exciting, but because in a year when 91% of practices cannot recruit hygienists and administrative overload is a named driver of burnout, automating administrative work is a staffing strategy.
Integration. The determining question for any tool is whether its output lands inside the workflow — in the chart, the claim, the treatment plan — without a human retyping it. A slightly weaker system that writes into your platform beats a better one that requires copy and paste. Integration is where the ROI actually lives.
The overhead insight most groups miss
Here is a finding that reframes the whole exercise: overhead structure drives margin outcomes more than revenue level does. DSOs achieve lower overhead through centralized purchasing, not higher billings.
Margin ranges from roughly 28% to 60% across practice models, and where a practice lands is a function of cost discipline and revenue capture rather than market conditions alone.
That should be encouraging and uncomfortable in equal measure. Encouraging, because it means the ceiling is operational rather than external. Uncomfortable, because it removes the market as an excuse.
The number you must define before any transaction conversation
Net profit after owner salary averages 12.9% across general practices. Gross margin is commonly quoted at 30% to 40%. Practice EBITDA multiples for smaller practices are cited in the 1.8x to 2.7x range while large DSO platforms transact at 9–10x.
Those figures measure the same practice in radically different ways. Confirm which definition is in use before any transaction conversation. More deals go sideways over an undefined EBITDA definition than over the multiple itself — add-backs, owner compensation normalization, management fee treatment, and one-time expenses can move the same practice by 30% or more.
Where the sector is going
Consolidation continues but has changed character. Nearly 200 DSO transactions occurred in 2024, with the top ten DSOs supporting roughly 7,000 offices. The US DSO market reached $37.9 billion in 2024 with projected growth around 17.9% annually. But the strategy inside those transactions has shifted toward financial restructuring and operational consolidation rather than pure expansion.
Diversification of revenue is part of the response — membership plans and other predictable revenue streams are being used to counter margin erosion from stagnant reimbursement, with 35% of dentists planning to exit at least some insurance networks.
Monday morning
- Write down your EBITDA definition — exactly which add-backs, exactly how owner and doctor compensation is normalized. If two people in your organization would produce different numbers, fix that before anything else.
- Inventory your technology stack by location: practice management, imaging, phones, payments, patient communication. Count distinct systems. That count is a rough proxy for how much friction sits between you and every centralization initiative.
- Calculate net-adjusted collections against net production by location. Anything below 95% is recoverable margin. Rank the locations and start with the worst.
- Identify your three largest administrative labor sinks — usually verification, claims follow-up, and confirmation calls — and estimate the hours. That is your automation business case, denominated in a resource you cannot hire.
- Build a same-store growth number you would show a buyer: locations open at least twelve months, adjusted production, same period prior year, acquisitions excluded. If you have never produced this, produce it this month. It is the first thing diligence asks for and the last thing most groups have ready.
- Pick one margin lever and work it for two quarters. Revenue cycle first, because the causal link to EBITDA is direct and the payback is immediate.
The reframe
In a 13–16x market, a mediocre operator with access to capital could generate returns. At 9–10x, with margins compressing, that is no longer true.
What is left is the unglamorous work: collecting what you are owed, standardizing what you run on, automating what does not need a person, and growing the locations you already have. None of it makes a good press release.
All of it shows up in the number a buyer actually pays for.
Sources: Benesch Dental/DSO Intelligence Monthly Report, July/August 2026 (multiples compressed to 9–10x from 13–16x peaks; smaller practices 5–6x; shift toward operational excellence and same-store growth); Clerri 2026 DSO growth trends (5% EBITDA decline since 2022; $37.9B market 2024, 17.9% CAGR; ~200 transactions in 2024; top 10 DSOs ~7,000 offices; 35% planning network exits); Planet DDS 2026 Dental Industry Outlook (EBITDA as engineered; technology standardization, RCM, automation, integration; $890K gap for a $10M group; NCR 88.9%; AR >90 days ~55%); Patient Prism 2026 profit margin research citing PorterKinney and ADA data (12.9% net profit after owner salary; 28–60% margin range; 1.8x–2.7x practice EBITDA multiples; overhead structure over revenue level).
Leave a comment